Search Results for "growth hormone"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for growth hormone. Results 21 to 25 of 25 total matches.

Tirzepatide (Zepbound) for Chronic Weight Management

   
The Medical Letter on Drugs and Therapeutics • Dec 25, 2023  (Issue 1692)
of the drug to pregnant animals during organogenesis was associated with fetal growth reductions ...
The injectable glucose-dependent insulinotropic polypeptide (GIP)/glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide, which was approved by the FDA as Mounjaro for treatment of type 2 diabetes in 2022, has now been approved as Zepbound (Lilly) for chronic weight management in adults who have a BMI ≥30 kg/m2 or a BMI ≥27 kg/m2 and at least one weight-related comorbidity. The injectable GLP-1 receptor agonists liraglutide (Saxenda) and semaglutide (Wegovy) are approved for chronic weight management in patients ≥12 years...
Med Lett Drugs Ther. 2023 Dec 25;65(1692):205-7   doi:10.58347/tml.2023.1692c |  Show IntroductionHide Introduction

Tirzepatide (Mounjaro) for Type 2 Diabetes

   
The Medical Letter on Drugs and Therapeutics • Jul 11, 2022  (Issue 1654)
), a peptide hormone with activity at both glucose-dependent insulinotropic polypeptide (GIP) and glucagon ...
The FDA has approved tirzepatide (Mounjaro – Lilly), a peptide hormone with activity at both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, to improve glycemic control in adults with type 2 diabetes. Tirzepatide, which is injected subcutaneously once weekly, is the first dual GIP/GLP-1 receptor agonist to become available in the US. Selective GIP receptor agonists are not available in the US; GLP-1 receptor agonists have been available for years.
Med Lett Drugs Ther. 2022 Jul 11;64(1654):105-7 |  Show IntroductionHide Introduction

Melatonin for Insomnia in Children

   
The Medical Letter on Drugs and Therapeutics • Jun 29, 2020  (Issue 1601)
:699. 10. BA Malow et al. Sleep, growth, and puberty after 2 years of prolonged-release melatonin ...
Over-the-counter products containing melatonin are widely used as sleep aids in children and adults.
Med Lett Drugs Ther. 2020 Jun 29;62(1601):103-4 |  Show IntroductionHide Introduction

Comparison Table: Some Oral/Transdermal Opioid Analgesics (online only)

   
The Medical Letter on Drugs and Therapeutics • Dec 12, 2022  (Issue 1665)
Can increase prolactin levels and reduce levels of sex hormones, resulting in reduced sexual function ...
View the Comparison Table: Some Oral/Transdermal Opioid Analgesics
Med Lett Drugs Ther. 2022 Dec 12;64(1665):e199-202 |  Show IntroductionHide Introduction

Opioids for Pain

   
The Medical Letter on Drugs and Therapeutics • Dec 12, 2022  (Issue 1665)
levels and decrease levels of sex hormones, resulting in reduced sexual function, decreased libido ...
A new CDC guideline for prescribing opioids for pain recently became available. Nonopioid drugs for pain were reviewed in a previous issue.
Med Lett Drugs Ther. 2022 Dec 12;64(1665):193-200 |  Show IntroductionHide Introduction